Cathay Capital, an investment firm, lead a €21m Series B round in Ganymed Robotics, a developer of computer vision software, with participation from Credit Mutuel Innovation, Kurma Partners, and BNP Paribas Développement. “The support of this high-profile group of investors, specialized in innovation and healthcare is a strong endorsement of the work accomplished and of our vision for the future of orthopedic surgery. We are eager to enter this new phase of growth. With our unique robot-with-eyes platform, we are committed to providing all surgeons and care centers, large and small, with an easy-to-use and cost-effective solution that will radically improve patient outcome, surgeon experience and overall efficiency of joint replacement interventions," Sophie Cahen, Ganymed Robotics Co-Founder and CEO.